Collegium Pharmaceutical Inc (COLL) recent activity suggests a positive outlook with the last week’s performance of 1.53%

A new trading day began on Tuesday, with Collegium Pharmaceutical Inc (NASDAQ: COLL) stock price up 3.45% from the previous day of trading, before settling in for the closing price of $34.74. COLL’s price has ranged from $20.83 to $40.95 over the past 52 weeks.

Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.

Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!

Get the FREE Report with all the details here.


Sponsored

It was noted that within the last five years, the titan of the Healthcare sector saw sales topped by 17.87%. Meanwhile, its annual earnings per share averaged 12.64%. With a float of $30.58 million, this company’s outstanding shares have now reached $31.87 million.

The extent of productivity of a business whose workforce counts for 197 workers is very important to gauge.

Collegium Pharmaceutical Inc (COLL) Insider and Institutional Ownership

As we move forward, let’s examine how large-scale investors are investing in this stock of the Drug Manufacturers – Specialty & Generic Industry. The insider ownership of Collegium Pharmaceutical Inc is 4.32%, while institutional ownership is 124.44%. The most recent insider transaction that took place on Feb 29 ’24, was worth 36,580. In this transaction EVP and Chief Medical Officer of this company sold 995 shares at a rate of $36.76, taking the stock ownership to the 63,409 shares. Before that another transaction happened on Feb 26 ’24, when Company’s EVP & Chief Commercial Officer sold 10,000 for $36.43, making the entire transaction worth $364,270. This insider now owns 138,918 shares in total.

Collegium Pharmaceutical Inc (COLL) Latest Financial update

According to the Wall Street analysts, stocks earnings will be around 12.64% per share during the next fiscal year.

Collegium Pharmaceutical Inc (NASDAQ: COLL) Trading Performance Indicators

Here are Collegium Pharmaceutical Inc’s current performance indicators. According to the last quarter’s results, the stock had a quick ratio of 1.10. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 2.03. Likewise, its price to free cash flow for the trailing twelve months is 4.19.

For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is 1.18, a number that is poised to hit 1.48 in the next quarter and is forecasted to reach 6.76 in one year’s time.

Technical Analysis of Collegium Pharmaceutical Inc (COLL)

The latest stats from [Collegium Pharmaceutical Inc, COLL] show that its last 5-days average volume of 0.36 million was inferior to 0.43 million than last year’s volume. As of the previous 9 days, the stock’s Stochastic %D was 22.56%. Additionally, its Average True Range was 1.19.

During the past 100 days, Collegium Pharmaceutical Inc’s (COLL) raw stochastic average was set at 68.27%, which indicates a significant increase from 27.20% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 28.65% in the past 14 days, which was lower than the 34.35% volatility it showed in the past 100 days.

At the time of writing, stock’s 50-day Moving Average is $36.86, while its 200-day Moving Average is $28.47. Now, the first resistance to watch is $36.66. This is followed by the second major resistance level at $37.37. The third major resistance level sits at $38.24. If the price goes on to break the first support level at $35.07, it is likely to go to the next support level at $34.21. The third support level lies at $33.49 if the price breaches the second support level.

Collegium Pharmaceutical Inc (NASDAQ: COLL) Key Stats

With a market capitalization of 1.15 billion, the company has a total of 32,706K Shares Outstanding. Currently, annual sales are 566,770 K while annual income is 48,160 K. The company’s previous quarter sales were 149,750 K while its latest quarter income was 31,940 K.